Cipher Pharma (CPHR) Said Considering Sale - Reuters

October 31, 2016 11:21 AM EDT
Get Alerts CPHR Hot Sheet
Trade CPHR Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

(Updated)

Cipher Pharma (NASDAQ: CPHR) has hired an investment bank to review strategic alternatives, including a potential sale, according to Reuters, citing people familiar with the matter.

The review comes amid increased scrutiny of specially drug prices, the report said.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk, Trading Halts

Add Your Comment